Arkolith/Insider Trading/ZIVO/Form 4

Yaldoo Laith L

Director, 10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Jun 16, 2025
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2025Buy(P)3K$14.33$50K558K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 13, 2025Buy(P)348$14.33$5K348

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-25-007028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML